References
- WHO. Resolution. Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2010 and Sustained support for polio-free status in the WHO European Region. Moscow, Russia, WHO Regional Office for Europe;2010. Available from: www.euro.who.int/__data/assets/pdf_file/0016/122236/RC60_eRes12.pdf
- WHO. Strategic plan for measles and congenital rubella infection in the WHO European Region. Copenhagen, Denmark, WHO Regional Office for Europe; 2003. Available from: www.euro.who.int/document/e81567.pdf
- ECDC. Surveillance report: measles and rubella monitoring, october 2013. Available from: www.ecdc.europa.eu/en/publications/Publications/measles-rubella-monitoring-February-2012.pdf
- WHO. Centralized Information System for Infectious Diseases (CISID). Measles-Number of cases, 2006-2013. Available from: http://data.euro.who.int/cisid
- Plans P. New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population. Eur J Clin Microbiol Infect Dis 2013.32:961-6. Available from: http://link.springer.com/article/10.1007%2Fs10096-013-1836-6
- Plans P, Torner N, Godoy P, Jané M. Lack of herd immunity against measles in individuals aged <35 years could explain re-emergence of measles in Catalonia (Spain). Int J Infect Dis 2014.18:81-3. Available from: http://download.journals.elsevierhealth.com/pdfs/journals/1201-9712/PIIS120197121300307X.pdf
- WHO. Regional office for Europe. Eliminating measles and rubella. Framework for the verification process in the WHO European Region. Copenhagen, Denmark, WHO Regional Office for Europe, 2012. Available from: www.euro.who.int/__data/assets/pdf_file/0005/156776/e96153-Eng-final-version.pdf
- Nardone A, Miller E; ESEN2 Group. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Euro Surveill 2004.9:5-7. Available from: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=456
- Andrews N, Pebody RG, Berbers G, et al. The European Sero-Epidemiology Network: standardising the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 2000;125:127-43
- Barbara C, Cotter S, et al. Towards elimination: measles susceptibility in Australia and 17 European countries. Bull WHO 2008.86:197-204. Available from: www.who.int/bulletin/volumes/86/3/07-041129.pdf
- Nardone A, Tischer A, Andrews N, et al. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull WHO 2008.86:118-25. Available from: www.who.int/bulletin/volumes/86/2/07-042010.pdf
- Plans-Rubió P. Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage. Human Vaccin Immunother 2012;8:184-8. Available from: www.landesbioscience.com/journals/vaccines/article/18444/2011HV0152R.pdf?nocache=2115884774
- Anderson RM, May RM. Infectious diseases in humans. In: Dynamics and control. Oxford University Press; Oxford, USA: 1992
- Papania MJ, Orenstein WA. Defining and assessing measles elimination goals. J Infect Dis 2004;189(Suppl 1):S23-6